Drug Search Results
More Filters [+]

MART-1:27-35

Alternative Names: mart-1:27-35, mart1:2735, mart 1:27 35
Latest Update: 2022-07-19
Latest Update Note: PubMed Publication

Product Description

For Melanoma and skin cancer (Sourced from: https://clinicaltrials.gov/ct2/show/NCT00923195)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Subcutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: National Cancer Institute (NCI)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for MART-1:27-35

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events